Tough challenges face pharmaceutical, medical devices and biotechnology companies today: longer time to market for new drugs or products; increased competition in a global marketplace; high research and development (R&D) costs; and complex compliance requirements. Addressing these challenges requires companies to rely on increasingly large, complex and interdependent applications that IT organizations have a hard time understanding and managing. To succeed, companies need to fully embrace IT to help grow the business, increase productivity and support innovation.
End-to-end business service management can help ease these woes. It maps end-to-end dependencies between infrastructure components, applications and the business processes they support. HP and BearingPoint have developed a Business Service Management solution for life sciences companies that provides IT organizations and application owners with real-time monitoring dashboards for applications and business processes. This holistic view of application monitoring facilitates communication and collaboration within and across IT support groups, allowing proactive responses to service degradations.
Read more about the benefits of end-to-end business service management and how it empowers life sciences companies to lead.